论文部分内容阅读
慢性前列腺炎(CP)患者的临床表现多样化,其中性功能改变是CP最常见症状之一。在芬兰一组CP调查中发现ED的发病率在43%。虽然导致ED的病因及可能的危险因素较多,而且临床上单纯低睾酮水平并不是ED的重要致病因素,但随着男子的老龄化,睾酮的作用效果下降较多。因此,在45～70岁的人群中可能会同时合并雄激素水平的下降。我院采用小剂量安特尔治疗中、老年人群中伴有ED的慢性前列腺炎,临床取得良好治疗效果。现将结果报告如下。资料和方法1．一般资料：本组患者96例,排除乳腺癌和前列腺癌及有症状的BPH。年龄45～70岁,平均(56．38±4．5)岁,病程8个月到10年,平均4．5年。慢性前列腺炎症状指数(NIH-CPSI)评分
Chronic prostatitis (CP) patients with diverse clinical manifestations, including changes in sexual function is one of the most common symptoms of CP. The incidence of ED was found in 43% in a Finnish CP survey. Although lead to the etiology and possible risk factors of ED more, and the clinical low testosterone level alone is not an important risk factor for ED, but with the aging of men, the effect of testosterone decreased more. Therefore, in the 45 to 70-year-old population may combine the androgen levels decline. Our hospital with a small dose of Atel treatment of middle-aged and elderly people with chronic prostatitis ED, clinically achieved good therapeutic effect. The results reported below. Data and methods 1. General Information: The group of 96 patients, excluding breast cancer and prostate cancer and symptomatic BPH. Aged 45 to 70 years, mean (56.38 ± 4.5) years of age, duration of 8 months to 10 years, an average of 4.5 years. Chronic Prostatitis Symptom Index (NIH-CPSI) score